After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
Apart from films, Amitabh Bachchan, the megastar of the century, is also in the limelight for his
BJP MP Ravi Shankar Prasad addressed a press conference on Congress' announcement of protests out
Why are Afghan soldiers so helpless in front of the Taliban?
The Taliban also took control of the capital of Afghanistan's strategically important Samangan pr
Former Indian spinner Ravichandran Ashwin made headlines with a bold statement after the Indian w
Prime Minister Narendra Modi on Friday joined the Shanghai Cooperation Organization (SCO) summit
Many players of the England cricket team have left IPL 2024 midway and returned home. The England
Gagandeep Kang, one of India's top virologists, said on Thursday that from what we know about the
Bollywood actor Sunny Deol is currently in the limelight for his upcoming film 'Jaat'. This film
External Affairs Minister S Jaishankar held a meeting with US Secretary of State Antony Blinken o
Just before the visit of President Draupadi Murmu to Punjab on Thursday, there was a stir due to
